Octreotide is a synthetic octapeptide that pharmacologically mimics natural somatostatin, with greater potency in inhibiting growth hormone, glucagon, and insulin. It primarily binds to somatostatin receptors SSTR2 and SSTR5 and was first synthesized in 1979.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 83150-76-9
Octreotide acetate
pharmaceutical raw material
Acetyl-Octreotide
pharmaceutical raw material
O-Acetyl Octreotide
pharmaceutical raw material
Octreotide Impurity 38
research compound
Astragaloside A
pharmaceutical raw material
Elagolix sodium
pharmaceutical raw material
Ofloxacin
pharmaceutical raw material
Desethylamiodarone
pharmaceutical raw material
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
DEQANNDTNATYII-OULOTJBUSA-N
C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O